Cancer Vaccines Market Report 2032: 7 Critical Insights on Therapeutic Pipelines, Immunotherapy Trends, and Global Revenue Forecast
8 mRNA Cancer Vaccine Trials Advancing Through Global Oncology Pipelines in 2026 The United States National Cancer Institute's 2026 Annual Report to the Nation, released in January, identifies mRNA-based therapeutic vaccines as the fastest-growing category in the US oncology pipeline — with 34 active investigational new drug applications filed in the 12 months ending December 2025, a...
0 Commenti 0 condivisioni 25 Views 0 Anteprima